肥胖不会影响接受体外受精及胚胎移植患者的疗效

• 作 者: Dechaud H. Anahory T. Reyftmann L. 朱晓明
• 机 构: Service de Gynécologie-Obstétrique et Médecine de la Reproduction CHU Arnaud De Villeneuve Facultéd
• 出 处: 世界核心医学期刊文摘(妇产科学分册)
• 发表日期: 2006年10期
• 关键词: 体外受精 男方因素 卵泡刺激素 种植率 妊娠率 卵母细胞 卵泡成熟 输卵管因素 诊断记录 激动剂

Objective: To examine the outcome of in vitro fertilization according to the body mass index of infertile patients. Study design: Between September 2003 and May 2005, 573 patients underwent 789 in vitro fertilization cycles or ICSI because of male factor, tubal factor, and unexplained infertility were retrospectively included from our IVF database. The patients were classified in four groups: BMI< 20 kg/m2(264 cycles), 20 ≤BMI< 25(394 cycles), 25 ≤BMI< 30(83 cycles), and BMI ≥30(48 cycles). All patients had a long protocol for IVF with a combination of the GnRH agonist and recombinant FSH. Results: All parameters of ovarian response were comparable except the total required r-FSH dose. This dose was statistically higher in the group of BMI ≥30 compared to the other groups (p=0.0003). All parameters of IVF outcome were comparable, including the cancellation rate, the implantation rate, and pregnancy rates. Conclusion: Obese patients require a higher r-FSH dose to achieve follicular maturation than normal weight patients. Obesity does not affect negatively results of in vitro fertilization.

Objective: To examine the outcome of in vitro fertilization according to the body mass index of infertile patients. Study design: Between September 2003 and May 2005, 573 patients underwent 789 in vitro fertilization cycles or ICSI because of male factor, tubal factor, and unexplained The patients were retrospectively included from our IVF database. The patients were classified in four groups: BMI <20 kg / m2 (264 cycles), 20 ≤ BMI <25 (394 cycles), 25 ≤ BMI <30 All patients had a long protocol for IVF with a combination of the GnRH agonist and recombinant FSH. Results: All parameters of ovarian response were comparable except the total required r-FSH dose. This dose was greater than in the group of BMI ≥30 compared to the other groups (p = 0.0003). All parameters of IVF outcome were comparable, including the cancellation rate, the implantation rate, and pregnancy rates. Conclusion: Obese patients require a higher r-FSH dose to achieve follicu lar maturation than normal weight patients. Obesity does not affect negatively results of in vitro fertilization.